Retour
Fourchette du Jour
84,94 €
88,39 €
Fourchette 52 Semaines
36,88 €
109,28 €
Volume
885 313
Moyenne 50J / 200J
96,02 €
/
73,30 €
Clôture Précédente
89,43 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -188,8 | 0,4 |
| P/B | 14,0 | 2,9 |
| ROE % | -8,7 | 3,9 |
| Net Margin % | -4,5 | 3,8 |
| Rev Growth 5Y % | 128,5 | 10,0 |
| D/E | 1,0 | 0,2 |
Objectif de Cours des Analystes
Hold
116,70 €
+32.8%
Low: 95,00 €
High: 140,00 €
BPA Prévisionnel
-1,62 €
CA Est.
640 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
7,51 €
6,93 € – 8,01 €
|
1,6 B | 5 |
| FY2029 |
4,85 €
4,47 € – 5,17 €
|
1,3 B | 2 |
| FY2028 |
1,84 €
-0,16 € – 4,30 €
|
990 M | 7 |
Points Clés
Revenue grew 128,45% annually over 5 years — strong growth
Generating 54,87M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 73,71%
Capital efficient — spends only 0,18% of revenue on capex
Croissance
Revenue Growth (5Y)
128,45%
Revenue (1Y)54,74%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-8,65%
ROIC-2,62%
Net Margin-4,48%
Op. Margin-4,25%
Sécurité
Debt / Equity
1,02
Current Ratio2,67
Interest Coverage-1,54
Valorisation
P/E Ratio
-188,82
P/B Ratio14,02
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 54,74% | Revenue Growth (3Y) | 67,25% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 128,45% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 521,31M | Net Income (TTM) | -23,36M |
| ROE | -8,65% | ROA | -2,77% |
| Gross Margin | 80,71% | Operating Margin | -4,25% |
| Net Margin | -4,48% | Free Cash Flow (TTM) | 54,87M |
| ROIC | -2,62% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1,02 | Current Ratio | 2,67 |
| Interest Coverage | -1,54 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -188,82 | P/B Ratio | 14,02 |
| P/S Ratio | 8,46 | PEG Ratio | 2,28 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 4,41B | Enterprise Value | 4,43B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 521,31M | 336,89M | 186,37M | 77,06M | 19,14M |
| Net Income | -23,36M | -87,94M | -163,42M | -135,67M | -83,99M |
| EPS (Diluted) | -0,47 | -1,85 | -4,00 | -4,02 | -2,77 |
| Gross Profit | 420,73M | 255,25M | 139,34M | 64,69M | 17,24M |
| Operating Income | -22,14M | -87,61M | -109,15M | -131,22M | -173,41M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 842,81M | 670,75M | 646,62M | 352,91M | 294,65M |
| Total Liabilities | 528,12M | 445,11M | 397,95M | 210,87M | 174,44M |
| Shareholders' Equity | 314,69M | 225,64M | 248,67M | 142,04M | 120,21M |
| Total Debt | 319,45M | 317,76M | 308,14M | 2,19M | 2,61M |
| Cash & Equivalents | 296,68M | 222,50M | 286,33M | 28,00M | 31,34M |
| Current Assets | 549,68M | 392,79M | 387,54M | 190,23M | 166,59M |
| Current Liabilities | 205,80M | 126,55M | 87,06M | 64,73M | 42,60M |